Premium
Artificial Saliva in the Management of Patients Suffering from Xerostomia
Author(s) -
'sGravenmade E.J.,
Vissink A.,
Panders A.K.,
Vermey A.
Publication year - 1984
Publication title -
gerodontology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.7
H-Index - 54
eISSN - 1741-2358
pISSN - 0734-0664
DOI - 10.1111/j.1741-2358.1984.tb00049.x
Subject(s) - medicine , saliva , dry mouth , dentistry , mucositis , sensation , mucin , pathology , chemotherapy , neuroscience , biology
Hyposalivation results in the sensation of a dry mouth “subjective xerostomia.” Besides the sensation of a dry mouth in serious conditions, distressing clinical symptoms are observed, e.g. difficulties in oral functioning, mucositis, progressive dental caries and nocturnal oral discomfort. A mucin‐containing artificial saliva to relieve patients'complaints from xerostomia has been developed. Its chemical and physical properties are demonstrated. In a 3‐year retrospective study the efficacy of this substitute and a CMC‐containing saliva has been evaluated for a total of 137 patients. Patients were free in choosing a mucin‐ or CMC preparation. Ninety‐six patients reported a considerable relief of their complaints with mucin‐saliva, one patient wished to continue using the CMC product. To increase efficacy of the saliva substitute on intra‐oral saliva reservoir has been developed for dentate and edentulous persons.